Literature DB >> 28179457

Microtubule motors involved in nuclear movement during skeletal muscle differentiation.

V Gache1, E R Gomes2,3, B Cadot2.   

Abstract

Nuclear positioning is a determining event in several cellular processes, such as fertilization, cell migration, and cell differentiation. The structure and function of muscle cells, which contain hundreds of nuclei, have been shown to rely in part on proper nuclear positioning. Remarkably, in the course of muscle differentiation, nuclear movements along the myotube axis might represent the event required for the even positioning of nuclei in the mature myofiber. Here we analyze nuclear behavior, time in motion, speed, and alignment during myotube differentiation and temporal interference of cytoskeletal microtubule-related motors. Using specific inhibitors, we find that nuclear movement and alignment are microtubule dependent, with 19 microtubule motor proteins implicated in at least one nuclear behavior. We further focus on Kif1c, Kif5b, kif9, kif21b, and Kif1a, which affect nuclear alignment. These results emphasize the different roles of molecular motors in particular mechanisms.
© 2017 Gache et al. This article is distributed by The American Society for Cell Biology under license from the author(s). Two months after publication it is available to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28179457      PMCID: PMC5385935          DOI: 10.1091/mbc.E16-06-0405

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


INTRODUCTION

The skeletal muscle fiber is a syncytium resulting from the fusion of hundreds of myoblasts (Abmayr and Pavlath, 2012). Muscle cells represent the main vertebrate cell type and are specialized to contract, and thus are responsible for voluntary movements. During muscle development or regeneration, nuclei are first found in the center of myotubes and then migrate to the periphery of mature skeletal myofibers (Bruusgaard ). Proper nuclear positioning is required for muscle function (Metzger ), and nuclear mispositioning is a hallmark of different muscle disorders, such as centronuclear myopathies (Jungbluth ). Multiple nuclear movement events occur during myofiber development to localize precisely each individual nucleus (Cadot ; Metzger ; Wilson and Holzbaur, 2012, 2015; Falcone ). The first nuclear migration event in muscle development takes place just after fusion, when the nucleus from a fusing myoblast rapidly migrates toward the center of the myotube. This process is called centration (Cadot ). Second, nuclei spread to become evenly spaced along the length of developing myotubes (Metzger ), a step called spreading. These two events were proposed to rely on the microtubule (MT) network and on some motor proteins. Finally, as myotubes mature into myofibers, nuclei migrate from the center to the periphery of the fiber by a mechanism dependent on N-Wasp, an actin regulator, and amphiphysin-2, a BAR protein mutated in centronuclear myopathies. This nuclear migration is termed dispersion (Falcone ). Nuclear positioning in cells appears to be a key mechanism required for multiple developmental processes in order to maintain functionally efficient muscle or brain (Dauer and Worman, 2009). These processes are described as being driven by MTs or actin (Gundersen and Worman, 2013). Even though recent advances in understanding nuclei position in developing muscle cells reveal an important role of MTs and some MT motors (kinesins and dyneins; Cadot ; Metzger ; Wilson and Holzbaur, 2012), the contribution of other MT motors to nuclei position during myofiber formation remains unexplored. Here we present a comprehensive analysis of MT-related molecular motor involvement in nuclear spreading during myofiber development. We use time-lapse microscopy combined with a small interfering RNA (siRNA) screen targeting all MT-related molecular motors (kinesins and dyneins) of the mouse genome to identify their involvement. These results highlight the variable effects of molecular motors on particular mechanisms in the early phases of myofiber development, such as nuclear alignment, time in motion, and speed of nuclei inside myotubes.

RESULTS AND DISCUSSION

Nuclear movements contribute to nuclei alignment inside myotubes

Nuclear movements occur in both primary differentiated muscle cells and C2C12s (Figure 1A; Englander and Rubin, 1987; Cadot ; Metzger ; Wilson and Holzbaur, 2012). We therefore used C2C12 muscle cells (Cadot ), stably expressing green fluorescent protein (GFP)–histone H1, to quantify nuclear behaviors during myotube formation using time-lapse microscopy. Nuclei within myotubes follow different behaviors, suggesting that multiple forces are applied to nuclei, driving their displacement along developing myofibers. To better characterize these nuclear migrations, we tracked each nucleus inside myotubes during the first 4 d of myofiber development and analyzed nuclear movements using SkyPad (Cadot ) to extract speed and percentage of time in motion. We also quantified nuclei distribution in myotubes to measure whether the resulting forces on each nucleus lead to a “nuclei alignment” organization (Metzger ). Finally, we analyzed fusion index to correlate defects in nuclear behavior with differentiation. During differentiation, nuclei progressively reduce their movements (Supplemental Figure S1A), and after 4 d, nuclei are mostly spread along the myotube axis (Figures 1B and 2C; Metzger ). Reduction of speed and time in motion during differentiation suggests that nuclear movement is not driven by a unique mechanism. We therefore decided to perform our analysis of nuclear movement between 60 and 75 h of differentiation, where nuclei inside myotubes move 55% of the time (±1.3) at a speed of 0.278 μm/min (± 0.1), similar to previously published results on nuclei speed (Figure 1C; Wilson and Holzbaur, 2012).
FIGURE 1:

Role of MTs and actin in nuclear movement inside myotubes. (A) Frames from time-lapse two-channel movies (phase contrast and fluorescence) of differentiated GFP-H1-C2 cells in presence or absence of the indicated drugs (Supplemental Movie S1). The first frame of each representative 14-h movie shows a myotube with GFP-H1-C2 nuclei (green); the white rectangle corresponds to the region used to create the adjacent kymograph. (B) Histogram of nuclear distribution analysis in C2C12 myotubes: nontreated (Control), treated with 75 nM nocodazole (Ndz), 100 nM Taxol (Taxol), 200 nM jasplakinolide (Jaspla), or 10 nM cytochalasin D (CytoD), or transfected with GFP-spastin. Nuclear distribution is quantified as “aligned” if >70% of nuclei are aligned along the same axis; “aggregated” if >70% of nuclei do not align along the same axis; and “other” if nuclei are both aggregated and aligned in the same myotube. (C) Speed and (D) percentage of time in motion of nuclei inside C2C12 myotubes 2–3 d old in nontreated (Control), treated with 75 nM Ndz, 100 nM Taxol, 200 nM Jaspla, or 10 nM CytoD conditions or transfected with GFP-spastin. Red line indicates the median. Between 53 (CytoD) and 181 (Ctr) nuclei were monitored from three different experiments. Error bars, SEM. ***p < 0.001, **p < 0.01. (E) STA graph; color is representative of the p value after one-way analysis of variance (ANOVA) statistical test toward a decrease compared to control. ***p < 0.001, **p < 0.01, *p < 0.05.

FIGURE 2:

MT motor siRNA screen for nuclear movement and alignment in myotubes. (A) STA graph after silencing of kinesin or dynein members for nuclei inside myotubes after 3 d of differentiation. Colors are representative of the p values after one-way ANOVA statistical test toward a decrease (red) and increase (green) compared to control. ***p < 0.001, **p < 0.01, *p < 0.05. The percentage of remaining mRNA after silencing is also indicated. (B) Venn diagram to summarize the results obtained with siRNA screen, showing the distribution of genes implicated in one or more of the nuclear behaviors. Purple, proteins implicated in minus end–directed motion; blue, plus end–directed proteins. (C) Distribution of nuclei in myotubes and (D) number of nuclei per myotubes in five different conditions (Ctr, Kif5b, Kif1a, Kif1c, Kif9, and Kif21b siRNAs) after 88 h of differentiation. Spreading factor is the ratio between observed average distance and theoretical maximum distance between nuclei (41–76 myotubes). (E) Representative image of myotubes in each condition.

Role of MTs and actin in nuclear movement inside myotubes. (A) Frames from time-lapse two-channel movies (phase contrast and fluorescence) of differentiated GFP-H1-C2 cells in presence or absence of the indicated drugs (Supplemental Movie S1). The first frame of each representative 14-h movie shows a myotube with GFP-H1-C2 nuclei (green); the white rectangle corresponds to the region used to create the adjacent kymograph. (B) Histogram of nuclear distribution analysis in C2C12 myotubes: nontreated (Control), treated with 75 nM nocodazole (Ndz), 100 nM Taxol (Taxol), 200 nM jasplakinolide (Jaspla), or 10 nM cytochalasin D (CytoD), or transfected with GFP-spastin. Nuclear distribution is quantified as “aligned” if >70% of nuclei are aligned along the same axis; “aggregated” if >70% of nuclei do not align along the same axis; and “other” if nuclei are both aggregated and aligned in the same myotube. (C) Speed and (D) percentage of time in motion of nuclei inside C2C12 myotubes 2–3 d old in nontreated (Control), treated with 75 nM Ndz, 100 nM Taxol, 200 nM Jaspla, or 10 nM CytoD conditions or transfected with GFP-spastin. Red line indicates the median. Between 53 (CytoD) and 181 (Ctr) nuclei were monitored from three different experiments. Error bars, SEM. ***p < 0.001, **p < 0.01. (E) STA graph; color is representative of the p value after one-way analysis of variance (ANOVA) statistical test toward a decrease compared to control. ***p < 0.001, **p < 0.01, *p < 0.05. MT motor siRNA screen for nuclear movement and alignment in myotubes. (A) STA graph after silencing of kinesin or dynein members for nuclei inside myotubes after 3 d of differentiation. Colors are representative of the p values after one-way ANOVA statistical test toward a decrease (red) and increase (green) compared to control. ***p < 0.001, **p < 0.01, *p < 0.05. The percentage of remaining mRNA after silencing is also indicated. (B) Venn diagram to summarize the results obtained with siRNA screen, showing the distribution of genes implicated in one or more of the nuclear behaviors. Purple, proteins implicated in minus end–directed motion; blue, plus end–directed proteins. (C) Distribution of nuclei in myotubes and (D) number of nuclei per myotubes in five different conditions (Ctr, Kif5b, Kif1a, Kif1c, Kif9, and Kif21b siRNAs) after 88 h of differentiation. Spreading factor is the ratio between observed average distance and theoretical maximum distance between nuclei (41–76 myotubes). (E) Representative image of myotubes in each condition.

Nuclear movement and alignment are mainly MT dependent

We first investigated the contribution of actin and MT networks to nuclear behavior inside myotubes. Because these two networks are essential for fusion (Dobi ; Cadot ), we applied drugs affecting MTs (nocodazole and Taxol) and actin (cytochalasin D and jasplakinolide) 3 d after differentiation. After testing a range of concentrations, we used concentrations that did not affect global shape of myotubes but did impair cytoskeletal dynamics (Brown and Spudich, 1979; Schiff and Horwitz, 1980; Vasquez ; Bubb ; Rotsch and Radmacher, 2000). Surprisingly, some parameters, such as time in motion, are only slightly modified by actin-targeted drugs. Percentage of time in motion decreased from 55% in control to 34% in 25 nM cytochalasin D and to 45% in 200 nM jasplakinolide (Figure 1, A and D). However, other characteristics are more drastically affected, such as nuclei speed, which decreased to 0.20 μm/min in cytochalasin D– and 0.23 μm/min in jasplakinolide-treated myotubes, compared with 0.27 μm/min in controls (Figure 1C and Supplemental Movie S1). Of interest, drugs targeting the actin network did not affect the alignment of nuclei in myotubes (Figure 1C). To hamper MT dynamics without affecting the overall shape of myotubes, we used drugs at low concentrations (75 nM nocodazole and 100 nM Taxol). Some parameters are highly modified during the first 24-h exposure, such as a dramatic decrease in the percentage of time in motion compared with control (Figure 1, A and D). Nuclear speed inside myotubes also decreases in nocodazole- and Taxol-treated myotubes (Figure 1C and Supplemental Movie S1A). To confirm MT involvement in maintaining these parameters, we overexpressed constitutively active spastin, a MT-severing protein (White ). We previously found that expression of spastin, but not the non–MT-severing mutant, prevents nuclear movement after fusion (Cadot ). We now found that ectopic expression of spastin in myotubes dramatically reduces nuclear motion and organization (Figure 1, B–D). To facilitate our readout, we represented the three measured parameters in an STA graph (speed, time in motion, and alignment), as represented in Figure 1E. These results describe the initial step of myofiber formation—when nuclei move extensively to establish an elongated myotube containing aligned nuclei. These results demonstrate the paramount role of dynamic MTs in nuclear movement within the myotube.

Identification of MT motors involved in nuclear spreading in myotubes

Next we sought to identify the MT-related molecular motors implicated in nuclear movement behavior. We performed an siRNA screen with three different sequences for each known kinesin and cytoplasmic dynein subunit (56 proteins; Table 1). STA parameters were measured in three different experiments on an area of 3.79 mm², corresponding to a single field of view under the microscope at a 4× magnification. We also quantified the fusion index to monitor the effect of protein silencing on the fusion process (Supplemental Figure S1C). At 36 h after silencing, cells were induced to differentiate into myotubes. Nuclear trajectories were analyzed using SkyPad (Cadot ) from 60 to 75 h after the induction of differentiation (Supplemental Figure S2, A and B). At this time, the initial fusion events and their associated nuclear movements (centration) are terminated, and myotubes contain enough nuclei to be monitored for their displacements. The last frame of each movie was used to quantify nuclei alignment in myotubes and fusion index (Supplemental Figures S1C and S2C). The data were compiled in an STA graph, allowing an easy overview of the effect of all kinesins and dynein members on nuclear movement behavior (Figure 2A). In our conditions, cells divide at least once before differentiation. Therefore depletion of motors implicated in the cell division process leads to massive cell death: Kif11 (Eg5), which is an establisher of the bipolar spindle (Blangy ), Kif23 (MKLP-1), and Kif12, which is known to be essential for cytokinesis (Lakshmikanth ; Zhu ). Depletion of two other kinesins leads to failure in differentiation: Kifc3, responsible for Golgi positioning and integration (Xu ), and Kif3c, a kinesin whose function remains to be elucidated (Yang ). We were still able to quantify the fusion index for the remaining cells, but the nuclei number per myotube (two to five) was too low to allow correct quantification of the other STA parameters. Of interest, dynein motor inhibition does not lead to any gross cell fusion defects (Figure 2A and Supplemental Figure S1C). Furthermore, we did not find any correlation between defects in nuclei behavior and fusion index. For example, Kif5b or Kif20a depletion affects uniquely nuclear movement or fusion index, respectively. It is important to note that efficiency of knockdown might have affected the functional readouts. We therefore measured the percentage of remaining mRNA for most targets by Taqman (Figure 2A) or at the protein level by Western blot (Supplemental Figure S1B).
TABLE 1:

siRNA sequences and Taqman probes used for each molecular motor.

RefSeq accession numberGene symbolSense siRNA sequenceAntisense siRNA sequenceTaqman assay ID
NM_008440Kif1aGGACAUCAACUAUGCCUCUttAGAGGCAUAGUUGAUGUCCtcMm00492863_m1
GGAAACAGAGAAGAUCAUUttAAUGAUCUUCUCUGUUUCCtt
CCAAGUCCUUCAUCGAAUAttUAUUCGAUGAAGGACUUGGtc
NM_207682Kif1bCGGGCUGAUUCAACUGGUGttCACCAGUUGAAUCAGCCCGttMm00801827_m1
CCUCAAUGAAGACCCAUUAttUAAUGGGUCUUCAUUGAGGtt
GGAUGGAAUUACAAGGGUUttAACCCUUGUAAUUCCAUCCtt
NM_153103Kif1cCCUUCGACUAUUCUUACUGttCAGUAAGAAUAGUCGAAGGtgMm00462184_m1
GGAAACAGAGAAGAUCAUAttUAUGAUCUUCUCUGUUUCCtg
CCAUGUUUUCCGCUUCAAUttAUUGAAGCGGAAAACAUGGtt
NM_008442Kif2aGGGAAUUUAUGCAUUAGCAttUGCUAAUGCAUAAAUUCCCttMm00515233_m1
CGCAGAUCAAUUUUCAUAGttCUAUGAAAAUUGAUCUGCGtt
GCUCCUAAUGAAAUGGUUUttAAACCAUUUCAUUAGGAGCtg
NM_134471Kif2cGGAGGUACCACAAAAGGCAttUGCCUUUUGUGGUACCUCCttMm00728630_s1
GGCAAAGAGAUUGACAUUGttCAAUGUCAAUCUCUUUGCCtt
GCAGAAAUUAACAAGUCUCttGAGACUUGUUAAUUUCUGCtc
NM_008443Kif3aGGGCGACACAAGGUUUUUGttCAAAAACCUUGUGUCGCCCtcMm01288585_m1
GGGACCAAGCAGGUAAAAAttUUUUUACCUGCUUGGUCCCtt
CCGUAAUUGAUUCUUUACUttAGUAAAGAAUCAAUUACGGtc
NM_008444Kif3bGGAUUUGUCUUCUUUUGUCttGACAAAAGAAGACAAAUCCttMm00492891_m1
GGUGGUAGAUGCGGAUGUGttCACAUCCGCAUCUACCACCtt
GGGUUUCAAUGGCACAAUUttAAUUGUGCCAUUGAAACCCtg
NM_008445Kif3cGGAGAAUCCUGAAACAGGGttCCCUGUUUCAGGAUUCUCCttMm00492900_m1
GGAAGAUGAUAACAACAACttGUUGUUGUUAUCAUCUUCCtc
CCGGCUAUCUUUGAGAUGGttCCAUCUCAAAGAUAGCCGGtg
NM_008446Kif4GGUGGUGGUUGGUAAUGAUttAUCAUUACCAACCACCACCtgMm00492908_m1
GGAAGAGGUCUUUAAUACAttUGUAUUAAAGACCUCUUCCtg
GGAUACAAUGCAACUGUCCttGGACAGUUGCAUUGUAUCCtt
NM_177052Kif6CCUGGCAGAUGGAUUCGUAttUACGAAUCCAUCUGCCAGGtcMm00723857_m1
GCUUCAACCCGGUCACACUttAGUGUGACCGGGUUGAAGCtt
CGAAUGUGGCUAUGACCUGttCAGGUCAUAGCCACAUUCGtt
NM_010628Kif9GGACUUGGUUUAUGAAACAttUGUUUCAUAAACCAAGUCCtgMm00495130_m1
GCAUCGACAUCCACUUGAAttUUCAAGUGGAUGUCGAUGCtt
GGCUUGUCAGUGCAUCUCAttUGAGAUGCACUGACAAGCCtt
NM_010615Kif11CCAUUUAAUCUGGCAGAGCttGCUCUGCCAGAUUAAAUGGtcMm01204225_m1
GCUUGUUAAAAUUGGAAAGttCUUUCCAAUUUUAACAAGCtc
GGUCUACUGAUAUAAUCAAttUUGAUUAUAUCAGUAGACCtc
NM_010616Kif12CCUGGCUAUUAGAUCGCGUttACGCGAUCUAAUAGCCAGGtgMm00802885_m1
CCUGAGUCUCGGUUCACAAttUUGUGAACCGAGACUCAGGtt
CCUUCACCUGGCUAUUAGAttUCUAAUAGCCAGGUGAAGGtc
NM_010617Kif13aGGUAUCGUAUAUGGAGAUCttGAUCUCCAUAUACGAUACCtcMm00660179_m1
GGGAAAUAAGUCUCGAACGttCGUUCGAGACUUAUUUCCCtc
GCUGGAGAAUAAGCUAAUUttAAUUAGCUUAUUCUCCAGCtt
NM_010620Kif15GGAGUCUGUAUUCUCAACAttUGUUGAGAAUACAGACUCCtgMm01341275_m1
GCGGUUAUAAUGGGACCAUttAUGGUCCCAUUAUAACCGCtc
GCAAACCUCAAUCUUGAAAttUUUCAAGAUUGAGGUUUGCtt
NM_010623Kif17GGCAGUGGGAAGUCUUUCAttUGAAAGACUUCCCACUGCCtgMm00456740_m1
GGAGGCCACCAAAAUUAACttGUUAAUUUUGGUGGCCUCCtt
CCCUGAUGAAUAAGGACUCttGAGUCCUUAUUCAUCAGGGtg
NM_139303Kif18aGGCGGUGCAGUUCUGUAAAttUUUACAGAACUGCACCGCCttMm01327661_m1
GCCAAUCCUUCAUAGUUUUttAAAACUAUGAAGGAUUGGCtt
CGUGCUUAAACUUACUCCAttUGGAGUAAGUUUAAGCACGtt
NM_028547Kif2bCCAAUGAACUAGUUUACCATTUGGUAAACUAGUUCAUUGGATMm01308520_s1
CGACAAUACGAAUUCGGGATTUCCCGAAUUCGUAUUGUCGTT
GCUCCAAUCACUACGAGAATTUUCUCGUAGUGAUUGGAGCTT
NM_010626Kif7GGAGAACGGCUCAAAGAGATTUCUCUUUGAGCCGUUCUCCGGMm01320530_m1
GCCUGGAGAUUGAUAGCAATTUUGCUAUCAAUCUCCAGGCGT
CAACAGCAAAAGAUCCUGATTUCAGGAUCUUUUGCUGUUGCT
NM_001081177Kif13bAGACGGGCAUUGUACGGUATTUACCGUACAAUGCCCGUCUTGMm01314840_m1
GGCUAGAAGUAACAUCUGATTUCAGAUGUUACUUCUAGCCTC
CCAUCUCCCAUGGUGGUUATTUAACCACCAUGGGAGAUGGAG
NM_001081258Kif14CAGGGAUGCUGUUCGGAUATTUAUCCGAACAGCAUCCCUGCANot available
CCUCUGUUCGAGUUCGUAATTUUACGAACUCGAACAGAGGTA
GGAAAGUCCUAUACGAUGATTUCAUCGUAUAGGACUUUCCAG
NM_001081133Kif16bGUACAUAAUUCAACAUAUATTUAUAUGUUGAAUUAUGUACATMm01327880_m1
CACUUAGAGAAAUACCUCATTUGAGGUAUUUCUCUAAGUGTG
GGAUUUGGAUUUAAUAAUATTUAUUAUUAAAUCCAAAUCCAA
NM_001102615Kif19aGAAGGAGUCCUACACCAAATTUUUGGUGUAGGACUCCUUCCTMm01244862_m1
CAACUAUCGGGACAGCAAATTUUUGCUGUCCCGAUAGUUGAT
CAAUCUAUCUAGCAGCACATTUGUGCUGCUAGAUAGAUUGTC
NM_183046Kif20bCAACGGUAGAAGUAAGUAATTUUACUUACUUCUACCGUUGATMm01205010_m1
CCAACGAUCUAAGUGCAAATTUUUGCACUUAGAUCGUUGGTT
GCGAAUAAUUUGCAUGAUATTUAUCAUGCAAAUUAUUCGCCA
NM_001097621Kif26aUGACGAGUUUGAUGCUUAUTTAUAAGCAUCAAACUCGUCATTMm01339746_m1
GCCCUGAACGUAUGUCGAATTUUCGACAUACGUUCAGGGCCT
AGAUCAAGGUGUACGAAAUTTAUUUCGUACACCUUGAUCUCA
NM_009004Kif20aGGACCUGUUGUCAGACUGCttGCAGUCUGACAACAGGUCCttMm00436226_m1
GGUGAAAGUUUACCUUCGAttUCGAAGGUAAACUUUCACCtt
CGUACACCAUUCAAGGUACttGUACCUUGAAUGGUGUACGtt
NM_016705Kif21aGGAUAUUGCCAGUAAUUAAttUUAAUUACUGGCAAUAUCCtcMm00497322_m1
CCCAGUGCAUCGAAAAGCUttAGCUUUUCGAUGCACUGGGtg
CGAAGAGAUCAGUAAUAUGttCAUAUUACUGAUCUCUUCGtt
NM_019962Kif21bGGAAAAAGUUCCAAAAGAAttUUCUUUUGGAACUUUUUCCtgNot available
GGAGAAGAUGCUGUCUUGCttGCAAGACAGCAUCUUCUCCtt
GGCUGCUCAAAAAGAACAUttAUGUUCUUUUUGAGCAGCCtg
NM_145588Kif22GGAAGUCUAUGUAGGUUCAttUGAACCUACAUAGACUUCCtgMm01139072_m1
GGGCAGAAUGCCAGUGUACttGUACACUGGCAUUCUGCCCtt
GGAAAACUCUACCUUAUUGttCAAUAAGGUAGAGUUUUCCtt
NM_024245Kif23GGGCUAUCGACUCAACAGAttUCUGUUGAGUCGAUAGCCCtcMm00458527_m1
GGAAAAAGAGCAAAUUACUttAGUAAUUUGCUCUUUUUCCtg
GCAUAGGGUCAUUUCAAGCttGCUUGAAAUGACCCUAUGCtg
NM_024241Kif24GCCAAGAGGACAUUUGGCAttUGCCAAAUGUCCUCUUGGCtgMm01211351_m1
CCAGCAUUCACCUGACAAAttUUUGUCAGGUGAAUGCUGGtg
GCAUGUGGUACAGAUAGCUttAGCUAUCUGUACCACAUGCtt
NM_177757Kif26bGGAGAGAGAUGAAAUUUGAttUCAAAUUUCAUCUCUCUCCttNot available
CCUUCGAGACCUGUUGUCUttAGACAACAGGUCUCGAAGGtt
GCUCUCAGCAAAAACCGAGttCUCGGUUUUUGCUGAGAGCtt
NM_175214Kif27GGAUCUCUACUUCUAUAAGttCUUAUAGAAGUAGAGAUCCttMm00723524_m1
GGCCAUGUUGCAUCAGUUGttCAACUGAUGCAACAUGGCCtc
NM_053173Kifc1GGCUAAUAAGAAGUGAAGUttACUUCACUUCUUAUUAGCCtgMm03011779_m1
GGAACUGAAGGGCAAUAUCttGAUAUUGCCCUUCAGUUCCtg
GGCCAUUAACAGCAGUCUGttCAGACUGCUGUUAAUGGCCtg
NM_010630Kifc2GGAGGAACAGAGAGUUUGGttCCAAACUCUCUGUUCCUCCtcMm00495161_m1
GGUCAACCUUUAAAAAACAttUGUUUUUUAAAGGUUGACCtg
GCUGAGUAGACUUCGUCUGttCAGACGAAGUCUACUCAGCtc
NM_010631Kifc3GGGCAUGUAUAUAAUGUUCttGAACAUUAUAUACAUGCCCtgMm00516085_m1
CGACUACAAUGGGCUCAAGttCUUGAGCCCAUUGUAGUCGtt
GGUUAAUAGCAACAACCAGttCUGGUUGUUGCUAUUAACCtc
NM_008451Klc2GGCGGUGAUCCAGGGUUUAttUAAACCCUGGAUCACCGCCttMm00492945_m1
GGGUUUAGAGACCCUGAGAttUCUCAGGGUCUCUAAACCCtg
GGUGGUAGAACUGUUAAAAttUUUUAACAGUUCUACCACCtt
NM_146182Klc3CAAAUGUGGCCAAGACUAAttUUAGUCUUGGCCACAUUUGggMm00461422_m1
GGAGGCUAGCCCAAGAGAAttUUCUCUUGGGCUAGCCUCCgt
AUGGAAAACGUGGACGUUAttUAACGUCCACGUUUUCCAUag
NM_001025360Klc1GGAGGAGAAGAAACACCUGttCAGGUGUUUCUUCUCCUCCtcMm00492936_m1
CCUAGCAGUACUGUACGGUttACCGUACAGUACUGCUAGGtt
GGGAUCAGAACAAGUAUAAttUUAUACUUGUUCUGAUCCCtg
NM_197959Kif18bCGAGCGGAUGCUGGUAUUUttAAAUACCAGCAUCCGCUCGtcMm01253048_g1
GCCGAGCAGUUACUUGAGAttUCUCAAGUAACUGCUCGGCtg
CCUACGAGGAUACUUACAAttUUGUAAGUAUCCUCGUAGGtc
NM_173762CenpeGGUUCAAGAACUUAAGACAttUGUCUUAAGUUCUUGAACCttMm00620549_m1
GGAAAUGCUCAAAGAUUUUttAAAAUCUUUGAGCAUUUCCtc
GGAUUACUGAUCUCCAAAAttUUUUGGAGAUCAGUAAUCCtt
NM_030238Dync1h1GGAGAAAGAAUUCAUUUCCttGGAAAUGAAUUCUUUCUCCtcMm00466548_m1
GCUCCUGUGAUUGAUGCAGttCUGCAUCAAUCACAGGAGCtc
GGAGGUUAUGUUUAAAACUttAGUUUUAAACAUAACCUCCtc
NM_010063Dync1i1GGAAGAGGAGAGGAAGAAGttCUUCUUCCUCUCCUCUUCCttMm01135515_m1
CCCAAAAUUGGUCAUGAUUttAAUCAUGACCAAUUUUGGGtt
GGAAGAAAAACAGCAGAUCttGAUCUGCUGUUUUUCUUCCtc
NM_010064Dync1i2CCAUUCUACGAGAAUUGUAttUACAAUUCUCGUAGAAUGGtcMm01333946_m1
GCAGAUUAACAUCUUCUUUttAAAGAAGAUGUUAAUCUGCtc
GGAAAGGAAAAAAAAGGAAttUUCCUUUUUUUUCCUUUCCtc
NM_007835Dctn1CCACAUCAAGUUCACCCAGttCUGGGUGAACUUGAUGUGGtcMm01184845_m1
GGAAGUAUUUCACAUGUGAttUCACAUGUGAAAUACUUCCtt
CCUGGAAACAUCAUGUAGUttACUACAUGAUGUUUCCAGGtc
NM_019682Dynll1GGAGUUUGACAAGAAGUACttGUACUUCUUGUCAAACUCCttMm00850282_g1
GGUGGCCAUUCUUCUGUUCttGAACAGAAGAAUGGCCACCtg
GGACUGCAUCCAAAUUCCAttUGGAAUUUGGAUGCAGUCCtt
NM_009342dynlt1GGAACCACAUGACUUCAGCttGCUGAAGUCAUGUGGUUCCtgNot available
GGCAGUACCACUUGUCUUAttUAAGACAAGUGGUACUGCCtg
GGUGCUAAAAACUCAAGUCttGACUUGAGUUUUUAGCACCtt
NM_025975Dynlt3GCAUAGUGGAACAGUCUAUttAUAGACUGUUCCACUAUGCttMm00458834_m1
GGCCAUUAACUUAAGUUUGttCAAACUUAAGUUAAUGGCCtt
GCCCGUAUGGAUUUCACACttGUGUGAAAUCCAUACGGGCtc
NM_025947Dynlrb1CCUUCCUUCGAAUUCGCUCttGAGCGAAUUCGAAGGAAGGttMm00508951_m1
GGCUUUGGAAUGAGAGCUUttAAGCUCUCAUUCCAAAGCCtg
GGCAUUCCCAUCAAGAGCAttUGCUCUUGAUGGGAAUGCCtt
NM_026556Dynll2GGCCAUGGAGAAGUACAACttGUUGUACUUCUCCAUGGCCtgNot available
GGACAUUGCUGCCUAUAUCttGAUAUAGGCAGCAAUGUCCtt
GGUCUGAAGUAUAGCAAUGttCAUUGCUAUACUUCAGACCtg
NM_029297dylnrb2GGAAUAUCUUCUGAUUGUCttGACAAUCAGAAGAUAUUCCttMm00466467_m1
CGAAUCCAUGAUAUUGUACttGUACAAUAUCAUGGAUUCGtg
CGACCUGACUUUUCUUAGGttCCUAAGAAAAGUCAGGUCGtt
NM_146229dync1li1CCGGCUAAGAAAGACAAUUttAAUUGUCUUUCUUAGCCGGtcMm01353886_m1
GCUACAGUCUCUUUUAGCAttUGCUAAAAGAGACUGUAGCtt
GCCUUGGACUGCUUUGGAUttAUCCAAAGCAGUCCAAGGCtt
NM_001013380dync1li2GCAGGUUAAGUAGCUGACAttUGUCAGCUACUUAACCUGCttDync1li2
CGUGCUGACUCAUAACCUGttCAGGUUAUGAGUCAGCACGtt
CGUAGCACUUCUUCUCUUAttUAAGAGAAGAAGUGCUACGtt
siRNA sequences and Taqman probes used for each molecular motor. We found eight minus end–directed motors or associated proteins and 11 plus end–directed motors involved in at least one nuclear movement behavior (Figure 2B), suggesting a high degree of complexity for the regulation of nuclear positioning in muscle cells. Several motors affect only one nuclear behavior; depletion of members of the kinesin-3 family (Kif13a, Kif13b), the dynein heavy chain (Dync1h1), and the dynein light chain LC8-type2 (Dynll2) solely increase nuclear speed. Kif13a and Kif13b are mainly involved in endosome trafficking (Delevoye , 2014). However, recent evidence demonstrated that the Drosophila homologue of Kif13b, khc73, is implicated, together with dynein heavy chain, in spindle positioning by anchoring MTs to the cell cortex (Lu and Prehoda, 2013). We previously showed that dynein is important in nuclear centration movement, probably through its localization at the nuclear envelope (Cadot ). In contrast, others found that depletion of dynein reduces nuclear speed in myotubes (Wilson and Holzbaur, 2012). These differences may stem from the fact that their measurements were done 168 h after differentiation, when nuclear movement characteristics (speed and percentage of time in motion) could be different from those in our analysis (60 h after differentiation). Because Dynll2 is involved in the formation of the dynein complex (Rapali ), its identification as playing a role in nuclear speed is in agreement with previous reports and emphasizes the connection between dynein and Kif13b. The time in motion of nuclei was reduced exclusively after silencing of Kif26a, Kif27, Dync1i1, Dync1i2, or Dync1li2. Little is known about the function of Kif26a and Kif27, whereas Dync1i1, Dync1i2, and Dync1li2 are cargo adapters for dynein. Their absence could thus induce a delay in the recruitment of motors involved in moving the nucleus. A few motors affect two types of nuclei behavior without altering others. Kif4 knockdown before differentiation leads to a decrease in speed and time in motion. Kif4 is known to be involved in the alignment of MTs in Xenopus (Mitchison ) and might have the same activity during myotube formation. Depletion of Kifc1, Kifc2, Dynlrb1, or Dynll1 affects both nuclei speed and time in motion but does not perturb nuclei alignment (Figure 2A). Kifc1, also known as HSET, is as a centrosome-clustering protein in cancers with supernumerary centrosomes (Chavali ) but is also capable of transporting the MT minus-end protein γ-tubulin (Lecland and Lüders, 2014). Because there is a relocalization of MT nucleation toward the nuclear envelope and a disappearance of centrosomes during differentiation (Tassin ), Kifc1 might affect these events and thereby perturb normal nuclear positioning. Unexpectedly, knockdown of kinesin light chain 1, 2, or 3 did not effect nuclear movement or organization. As previously suggested, however, redundancy of Klc1 and 2 may require double knockdown of these proteins to observe an effect on nuclear aggregation (Wilson and Holzbaur, 2015). As expected, only knockdown of the motor protein Kif5b altered the three types of nuclear behavior (Figure 2A). Kif5b was already implicated in nuclear rotation, movement, and positioning in muscle cells (Metzger ; Wilson and Holzbaur, 2012, 2015). Kif5b was also identified as the kinesin responsible for basally directing nuclear movement in neurons and thus contributing to neurogenesis (Tsai ).

Motors affecting nuclear alignment

Because nuclear alignment might depend on a complex mechanism, we decided to focus our attention on the five motor proteins whose depletion affects nuclei alignment: Kif5b, Kif1c, Kif1a, Kif9, and Kif21b. Kif9 couples centrosomes to nuclei (Tikhonenko ). Kif1a and Kif1c are mutated in spastic paraplegia (Caballero Oteyza ; Dor ; Citterio ), and Kif1a is associated with interkinetic nuclear movement in the developing brain (Tsai ; Carabalona ). Finally, Kif21b knockdown increases nuclear alignment in myotubes. We therefore further analyzed these phenotypes by measuring the spreading factor, that is, the ratio between the average observed distances between nuclei and the theoretically optimal distance. We found a similar reduction of this ratio in Kif5b-, Kif1a-, and Kif1c-knockdown myotubes (Figure 2C). Unexpectedly, this factor was nearly unchanged in myotubes depleted for Kif9 or Kif21b. Kif9-silenced myotubes display aggregated nuclei, but the phenotype is different from the one observed in Kif5b- or Kif1a-depleted myotubes. In the kif9 siRNA cohort, nuclei form distinct clusters along the length of the myotube, yielding a higher average distance between nuclei than in Kif5b-knockdown myotubes (Figure 2, C and E, and Supplemental Figure S2D). Concerning Kif21b depletion, the increase in the percentage of myotubes with aligned nuclei does not imply an increase in nuclear spreading. To understand whether these motors affect differentiation, we measured, besides the fusion index (Supplemental Figure S1CD), the number of nuclei per myotube, which represents myotube size (Figure 2D). Kif5b or Kif9 depletion shows an increase in the fusion index while maintaining a normal number of nuclei per myotube. This suggests that even if kif5b and kif9 affect nuclear positioning, they do not interfere with the myogenic program. On the other hand, Kif1a or Kif1c depletion does not affect the fusion index but affects the number of nuclei per myotube. The most plausible explanation is that this result stems from a reduction in the number of cells available for fusion. Kif1a or Kif1c must therefore have an effect on the cycle of division before differentiation. Nevertheless, both motors remain interesting candidates for nuclear aggregation. Finally, Kif21b depletion decreases both the fusion index and the number of nuclei per myotube, suggesting a dual role, one for nuclear alignment and one for differentiation. MT motors could affect nuclear movement and positioning by modifying MT organization or dynamics. To answer this question, we analyzed the orientation and length of EB1 comets in myotubes over a period of 200 s after depletion of a few motors (Supplemental Figure S1, D and E). This quantification of the MT growing plus ends allowed us to estimate the dynamics of the MTs and their organization. Most MTs grow parallel to the longest axis of the myotube (Supplemental Figure S1D). Only slight modifications in comet orientation were found after depletion of Kif5b or Dynlrb1, which could correlate with the observed differences in nuclear behavior. Surprisingly, the lengths of the EB1 comets were significantly modified after depletion of several motors without any correlation to their individual effects on nuclear movement (Supplemental Figure S1E). We hypothesize that normal nuclear movement might rely on different aspects—an oriented MT network, dynamic MTs, and molecular motors—to produce the necessary forces. The nucleus represents the biggest organelle in the cell, and these findings illustrate the complexity required to move as well as organize the distribution of multiple nuclei in a large muscle cell. Several interesting candidates remain to be explored for their specific role, such as the proteins affecting two parameters of nuclear behavior. This opens new routes of research toward understanding intracellular organization.

MATERIALS AND METHODS

Cell line

C2C12 cells were cultured in DMEM with 10% fetal bovine serum (Invitrogen) and antibiotics (penicillin at 100 U/ml and streptomycin at 100 μg/ml) and were plated on 0.1% gelatin-coated dishes or acid-washed coverslips for 1–2 d before differentiation. Differentiation was induced by switching to DM (DMEM with 1% horse serum).

Chemicals and plasmids

Drugs were applied on 48-h-differentiated C2C12 cells and directly time-lapse recorded during 10 h. STA parameters were quantified during this time period. Taxol was from Calbiochem (580555), nocodazole from Sigma-Aldrich (M1404), cytochalasin D from Calbiochem (250255), and jasplakinolide from Santa Cruz Biotechnology (sc-202191A). YFP-Δ-227-spastin (C-terminus truncation) was a gift from Brett Lauring (Columbia University, New York).

siRNA transfection

Cells were transfected with three different siRNAs per gene using RNAiMAX, following the manufacturer’s instructions (Life Technologies), 2 d before differentiation. For spastin cDNA transfection, we used Lipofectamine 2000 (Life Technologies), and cells were switched to DM 12 h after transfection. siRNAs were obtained from Life Technologies (primers used are listed in Table 1).

Microscopy

Epifluorescence images were acquired using a Nikon Ti microscope equipped with a CoolSNAP HQ2 camera (Roper Scientific) and an XY-motorized stage (Nikon) driven by MetaMorph (Molecular Devices). Multipositioning images were stitched with MetaMorph. For live imaging, we used an incubator to maintain cultures at 37°C and 5% CO2 (Okolab).

Quantification of nuclear movement and positioning inside myotubes

We used the SkyPad algorithm as previously described (Cadot ) to quantify speed and time in motion. Briefly, nuclei centroids positions were manually picked every 15 min over 15 h, and coordinates were transferred to an Excel spreadsheet before running the SkyPad algorithm. For nuclear positioning, we identified three possible situations: nuclei are spread along the myotube axis (aligned), nuclei are clustered together (aggregated), and there is a mix of both (other). To calculate the spreading factor, we measured the nuclei interdistances and the length of the myotube. The spreading factor is the observed average interdistance over the optimal interdistance, that is, the myotube length divided by the number of nuclei.

Quantification of fusion index and number of nuclei per myotubes

The fusion index was calculated as percentage of nuclei found inside myotubes (more than two nuclei) over the total number of nuclei present in the same area (3.79 mm2) at the end of each movie, 88 h after switching to differentiation medium.

Validation of siRNA knockdown by Western blot and reverse transcription quantitative PCR

At 48 h after silencing, cells were lysed in 1% SDS in phosphate-buffered saline (PBS) and passed through Qiashredder columns. Equal amounts of proteins were loaded on 4–12% gradient gels, followed by transfer on nitrocellulose membrane using the iBlot apparatus (Life Technologies). Primary antibodies were from Bethyl (Kif1b, Klc2), BD (Dcnt1), and Santa Cruz Biotechnology (kif5b). mRNAs from C2C12 cells were isolated with the RNeasy 96 Kit (Qiagen), and cDNA was prepared with the High-Capacity cDNA Reverse Transcription Kit (Life Technologies). Quantitative PCR (qPCR) analyses were performed using Taqman Gene Expression assay (Life Technologies; see Table 1) in a StepOne Plus system (Applied Biosystems). For Kif5b, Kif1a, and Kif26b, mRNAs from C2C12 cells were isolated with the RNeasy Micro Kit (Qiagen), and cDNA was prepared with the Transcriptor First-Strand cDNA Synthesis Kit (Roche). qPCR was performed using a CyberGreen Kit in a LightCycler 480 II system (Roche), using the following primers: Kif5b-F, 5′-GGAGGCAAGCAGTCGTAAAC-3′; Kif5b-R, 5′-TCTAGTGTTGGGAAGCAGCA-3′; Kif1a-F, 5′-GAAG­ACTCCCTCCCCTGTTC-3′, Kif1a-R, 5′-ATCTCTCCACCGTGTCC­TTG-3′, Kif26b-F, 5′-TGGGGAACCATTCGAAATTA, Kif26b-R, 5′-AGGACCTGCTCCAAGTCAAA-3′; Hprt1-F, 5′-GTTAAGCAGTACAGCCCCAAA-3′; and Hprt1-R, 5′-AGGGCATATCCAACAACAAACTT-3′.

Statistics

A Gaussian distribution of averaged speeds of each nucleus was tested using the D’Agostino and Pearson omnibus normality test for each condition (GraphPad software); it appeared that the distribution was not Gaussian, and so the statistical significance between conditions was measured using the Mann–Whitney test for non-Gaussian distributions. A normal Student’s t test was used otherwise.
  38 in total

1.  Nanomolar concentrations of nocodazole alter microtubule dynamic instability in vivo and in vitro.

Authors:  R J Vasquez; B Howell; A M Yvon; P Wadsworth; L Cassimeris
Journal:  Mol Biol Cell       Date:  1997-06       Impact factor: 4.138

2.  Characterization of early steps in muscle morphogenesis in a Drosophila primary culture system.

Authors:  Krista C Dobi; Thomas Metzger; Mary K Baylies
Journal:  Fly (Austin)       Date:  2011-04-01       Impact factor: 2.160

3.  Motor protein mutations cause a new form of hereditary spastic paraplegia.

Authors:  Andrés Caballero Oteyza; Esra Battaloğlu; Levent Ocek; Tobias Lindig; Jennifer Reichbauer; Adriana P Rebelo; Michael A Gonzalez; Yasar Zorlu; Burcak Ozes; Dagmar Timmann; Benjamin Bender; Günther Woehlke; Stephan Züchner; Ludger Schöls; Rebecca Schüle
Journal:  Neurology       Date:  2014-05-07       Impact factor: 9.910

4.  A NudE/14-3-3 pathway coordinates dynein and the kinesin Khc73 to position the mitotic spindle.

Authors:  Michelle S Lu; Kenneth E Prehoda
Journal:  Dev Cell       Date:  2013-08-26       Impact factor: 12.270

5.  Taxol stabilizes microtubules in mouse fibroblast cells.

Authors:  P B Schiff; S B Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

Review 6.  Centronuclear (myotubular) myopathy.

Authors:  Heinz Jungbluth; Carina Wallgren-Pettersson; Jocelyn Laporte
Journal:  Orphanet J Rare Dis       Date:  2008-09-25       Impact factor: 4.123

7.  Self-organization of stabilized microtubules by both spindle and midzone mechanisms in Xenopus egg cytosol.

Authors:  Timothy J Mitchison; Phuong Nguyen; Margaret Coughlin; Aaron C Groen
Journal:  Mol Biol Cell       Date:  2013-03-20       Impact factor: 4.138

8.  Acetylcholine receptor clustering and nuclear movement in muscle fibers in culture.

Authors:  L L Englander; L L Rubin
Journal:  J Cell Biol       Date:  1987-01       Impact factor: 10.539

9.  Cytochalasin inhibits the rate of elongation of actin filament fragments.

Authors:  S S Brown; J A Spudich
Journal:  J Cell Biol       Date:  1979-12       Impact factor: 10.539

10.  Fast, multi-dimensional and simultaneous kymograph-like particle dynamics (SkyPad) analysis.

Authors:  Bruno Cadot; Vincent Gache; Edgar R Gomes
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more
  19 in total

Review 1.  Getting into Position: Nuclear Movement in Muscle Cells.

Authors:  Mafalda Azevedo; Mary K Baylies
Journal:  Trends Cell Biol       Date:  2020-01-30       Impact factor: 20.808

2.  17β-estradiol alters mRNA co-expression after murine muscle injury and mild hypobaria.

Authors:  Scott Emory Moore; Joachim G Voss; Barbara St Pierre Schneider
Journal:  Exp Biol Med (Maywood)       Date:  2019-09-18

3.  Intercellular Adhesion Molecule-1 Enhances Myonuclear Transcription during Injury-Induced Muscle Regeneration.

Authors:  Kole H Buckley; Andrea L Nestor-Kalinoski; Francis X Pizza
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

4.  Increased nuclear but not cytoplasmic activities of CELF1 protein leads to muscle wasting.

Authors:  Diana C Cox; Xiangnan Guan; Zheng Xia; Thomas A Cooper
Journal:  Hum Mol Genet       Date:  2020-06-27       Impact factor: 6.150

5.  KIFC1 Regulates the Trajectory of Neuronal Migration.

Authors:  Hemalatha Muralidharan; Shrobona Guha; Kiran Madugula; Ankita Patil; Sarah A Bennison; Xiaohuan Sun; Kazuhito Toyo-Oka; Peter W Baas
Journal:  J Neurosci       Date:  2022-01-19       Impact factor: 6.709

6.  Mechanical positioning of multiple nuclei in muscle cells.

Authors:  Angelika Manhart; Stefanie Windner; Mary Baylies; Alex Mogilner
Journal:  PLoS Comput Biol       Date:  2018-06-11       Impact factor: 4.475

Review 7.  Microtubule Organization in Striated Muscle Cells.

Authors:  Robert Becker; Marina Leone; Felix B Engel
Journal:  Cells       Date:  2020-06-03       Impact factor: 6.600

Review 8.  Nesprins and Lamins in Health and Diseases of Cardiac and Skeletal Muscles.

Authors:  Alexandre Janin; Vincent Gache
Journal:  Front Physiol       Date:  2018-09-07       Impact factor: 4.566

9.  What Happened in the Hippocampal Axon in a Rat Model of Posttraumatic Stress Disorder.

Authors:  Yadi Guan; Xinzhao Chen; Beiying Zhao; Yuxiu Shi; Fang Han
Journal:  Cell Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.046

10.  Atrial Structural Remodeling Gene Variants in Patients with Atrial Fibrillation.

Authors:  Rosa Doñate Puertas; Gilles Millat; Isabelle Ernens; Vincent Gache; Samuel Chauveau; Elodie Morel; Emilie Christin; Nathalie Couturier; Yvan Devaux; Philippe Chevalier
Journal:  Biomed Res Int       Date:  2018-09-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.